BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23565491)

  • 1. Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle.
    Minokoshi Y; Toda C; Okamoto S
    Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 3):S562-8. PubMed ID: 23565491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.
    Minokoshi Y; Kim YB; Peroni OD; Fryer LG; Müller C; Carling D; Kahn BB
    Nature; 2002 Jan; 415(6869):339-43. PubMed ID: 11797013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.
    Miyamoto L; Ebihara K; Kusakabe T; Aotani D; Yamamoto-Kataoka S; Sakai T; Aizawa-Abe M; Yamamoto Y; Fujikura J; Hayashi T; Hosoda K; Nakao K
    J Biol Chem; 2012 Nov; 287(48):40441-7. PubMed ID: 23024365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of glucose uptake in skeletal muscle by central leptin is mediated by muscle β
    Shiuchi T; Toda C; Okamoto S; Coutinho EA; Saito K; Miura S; Ezaki O; Minokoshi Y
    Sci Rep; 2017 Nov; 7(1):15141. PubMed ID: 29123236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle.
    Palacios-González B; Zarain-Herzberg A; Flores-Galicia I; Noriega LG; Alemán-Escondrillas G; Zariñan T; Ulloa-Aguirre A; Torres N; Tovar AR
    Biochim Biophys Acta; 2014 Jan; 1841(1):132-40. PubMed ID: 24013029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36.
    Momken I; Chabowski A; Dirkx E; Nabben M; Jain SS; McFarlan JT; Glatz JF; Luiken JJ; Bonen A
    Biochem J; 2017 Jan; 474(1):149-162. PubMed ID: 27827305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic central leptin decreases food intake and improves glucose tolerance in diet-induced obese mice independent of hypothalamic malonyl CoA levels and skeletal muscle insulin sensitivity.
    Keung W; Palaniyappan A; Lopaschuk GD
    Endocrinology; 2011 Nov; 152(11):4127-37. PubMed ID: 21914780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans.
    Steinberg GR; McAinch AJ; Chen MB; O'Brien PE; Dixon JB; Cameron-Smith D; Kemp BE
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3592-7. PubMed ID: 16822822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the AMP-activated protein kinase in the regulation of energy homeostasis.
    Carling D
    Novartis Found Symp; 2007; 286():72-81; discussion 81-5, 162-3, 196-203. PubMed ID: 18269175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic control of lipid metabolism: focus on leptin, ghrelin and melanocortins.
    Diéguez C; Vazquez MJ; Romero A; López M; Nogueiras R
    Neuroendocrinology; 2011; 94(1):1-11. PubMed ID: 21576929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle.
    Minokoshi Y; Kahn BB
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):196-201. PubMed ID: 12546684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle.
    Martin TL; Alquier T; Asakura K; Furukawa N; Preitner F; Kahn BB
    J Biol Chem; 2006 Jul; 281(28):18933-41. PubMed ID: 16687413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis.
    Atkinson LL; Fischer MA; Lopaschuk GD
    J Biol Chem; 2002 Aug; 277(33):29424-30. PubMed ID: 12058043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep.
    Laker RC; Henry BA; Wadley GD; Clarke IJ; Canny BJ; McConell GK
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R511-8. PubMed ID: 21148475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism.
    Roman EA; Reis D; Romanatto T; Maimoni D; Ferreira EA; Santos GA; Torsoni AS; Velloso LA; Torsoni MA
    Mol Cell Endocrinol; 2010 Jan; 314(1):62-9. PubMed ID: 19698760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking leptin and insulin action: therapeutic opportunities for diabetes.
    Yildiz BO; Haznedaroglu IC
    Int J Biochem Cell Biol; 2006; 38(5-6):820-30. PubMed ID: 16236542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis.
    Ceddia RB
    Int J Obes (Lond); 2005 Oct; 29(10):1175-83. PubMed ID: 16030519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into sympathetic regulation of glucose and fat metabolism.
    Nonogaki K
    Diabetologia; 2000 May; 43(5):533-49. PubMed ID: 10855527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hypothalamic AMP-kinase in food intake regulation.
    Minokoshi Y; Shiuchi T; Lee S; Suzuki A; Okamoto S
    Nutrition; 2008 Sep; 24(9):786-90. PubMed ID: 18725075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic melanocortin signaling and leptin resistance--perspective of therapeutic application for obesity-diabetes syndrome.
    Masuzaki H; Tanaka T; Ebihara K; Hosoda K; Nakao K
    Peptides; 2009 Jul; 30(7):1383-6. PubMed ID: 19394382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.